サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1347543

グリコミクス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Glycomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 146 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
グリコミクス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界のグリコミクス市場規模は2022年に14億米ドルに達しました。今後、IMARC Groupは、同市場が2023年から2028年の間に12%の成長率（CAGR）を示し、2028年までに28億米ドルに達すると予測しています。

グリコミクスとは、細胞、組織、生物のグライコームの定義や定量化を支援する研究を指します。主に、1つの生物で産生される糖鎖の完全なセットの構造と機能を同定し、糖タンパク質をコードするすべての遺伝子を決定するのに役立ちます。また、細胞間情報伝達における糖-タンパク質相互作用の役割の解明にも役立ちます。その結果、グリコミクスは世界中の診断学、創薬、免疫学に広く応用されています。

グリコミクスの市場動向：

現在、座りっぱなしのライフスタイルや喫煙・飲酒者の増加により、慢性疾患の有病率が上昇しています。これに伴い、コロナウイルス感染症（COVID-19）の大流行は、世界の大流行の拡大を防ぐためのワクチンや治療薬の需要にプラスの影響を与えています。このことが、グリコミクス市場の成長を強化しています。これに加えて、グリコミクスは世界中でトレーニングや教育目的で好まれるようになってきています。このことは、糖鎖構造データ解析の採用増加による研究センターでの広範な適用可能性と相まって、市場成長に寄与しています。さらに、市場をリードする企業は、構造的に複雑な糖鎖を治療薬として採用する能力を高めるため、研究開発（R&D）活動に継続的に資金を投入しています。その結果、化学・生化学研究において、高速液体クロマトグラフィー（HPLC）、質量分析（MS）、キャピラリー電気泳動（CE）などの先端技術を開発しています。さらに、医薬品や生物製剤の開発・製造のための受託研究機関（CRO）の増加が市場を牽引しています。その他、製薬業界の繁栄、臨床試験数の増加、ヘルスケアインフラの改善などが市場成長を促進すると予測されています。

本レポートで扱う主な質問

  • 2022年の世界のグリコミクス市場規模は？
  • 2023-2028年の世界のグリコミクス市場の成長率はどの程度と予測されるか？
  • 世界のグリコミクス市場を牽引する主要因は何か？
  • COVID-19が世界のグリコミクス市場に与えた影響は？
  • グリコミクスの世界市場の製品別区分は？
  • グリコミクスの世界市場の用途別区分は？
  • グリコミクスの世界市場のエンドユーザー別区分は？
  • グリコミクスの世界市場における主要地域は？
  • グリコミクスの世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のグリコミクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 酵素
    • 市場動向
    • 主要セグメント
      • グリコシダーゼ
      • 糖転移酵素
      • ノイラミニダーゼ
      • シアル酸転移酵素
      • その他
    • 市場予測
  • 機器
    • 市場動向
    • 主要セグメント
      • 質量分析計
      • HPLC
      • MALDI-TOF
      • アレイシステム
      • その他
    • 市場予測
  • キット
    • 市場動向
    • 主要セグメント
      • 糖鎖標識キット
      • 糖鎖精製キット
      • グリカン放出キット
      • その他
    • 市場予測
  • 試薬
    • 市場動向
    • 主要セグメント
      • 糖タンパク質
      • 単糖類
      • オリゴ糖
      • その他
    • 市場予測

第7章 市場内訳：用途別

  • 創薬・医薬品開発
    • 市場動向
    • 市場予測
  • 診断
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 学術・研究機関
    • 市場動向
    • 市場予測
  • 製薬・バイオ企業
    • 市場動向
    • 市場予測
  • CRO（医薬品開発業務受託機関）
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Asparia Glycomics
    • Bruker Corporation
    • Danaher Corporation
    • Dextra Laboratories Limited（New Zealand Pharmaceuticals Limited）
    • Merck KGaA
    • New England Biolabs
    • RayBiotech Life Inc.
    • Shimadzu Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Glycomics Market: Major Drivers and Challenges
  • Figure 2: Global: Glycomics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Glycomics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Glycomics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Glycomics Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Glycomics Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Glycomics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Glycomics (Enzymes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Glycomics (Enzymes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Glycomics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Glycomics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Glycomics (Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Glycomics (Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Glycomics (Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Glycomics (Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Glycomics (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Glycomics (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Glycomics (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Glycomics (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Glycomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Glycomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Glycomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Glycomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Glycomics (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Glycomics (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Glycomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Glycomics Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Glycomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Glycomics Industry: SWOT Analysis
  • Figure 78: Global: Glycomics Industry: Value Chain Analysis
  • Figure 79: Global: Glycomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Glycomics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Glycomics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Glycomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Glycomics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Glycomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Glycomics Market: Competitive Structure
  • Table 7: Global: Glycomics Market: Key Players
目次
Product Code: SR112023A5689

Market Overview:

The global glycomics market size reached US$ 1.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2028, exhibiting a growth rate (CAGR) of 12% during 2023-2028.

Glycomics refers to a study that aids in defining or quantifying the glycome of a cell, tissue, or organism. It mainly assists in identifying the structure and function of the complete set of glycans produced in a single organism and determining all the genes that encode glycoproteins. It also aids in establishing the role of carbohydrate-protein interactions in cell-cell communication. As a result, glycomics finds extensive application in diagnostics, drug discovery, and immunology across the globe.

Glycomics Market Trends:

Presently, there is a rise in the prevalence of chronic diseases on account of sedentary lifestyles and the growing number of individuals who smoke and consume alcohol. In line with this, the coronavirus disease (COVID-19) outbreak has positively influenced the demand for vaccine and treatment drugs to prevent the spread of the pandemic worldwide. This, in turn, is strengthening the growth of the glycomics market. Besides this, glycomics is gaining preference for training and educational purposes around the world. This, in confluence with its extensive applicability in research centers due to the increasing adoption of glycan structure data analysis, is contributing to market growth. Furthermore, leading market players are continuously funding research and development (R&D) activities to enhance the ability of structurally complex glycans to be employed as therapeutics. Consequently, they are developing advanced technologies, such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and capillary electrophoresis (CE) in chemical and biochemical research. Moreover, a growing number of Contract Research Organizations (CROs) for the development and production of drugs and biologics is driving the market. Some of the other factors, such as the thriving pharmaceutical industry, rising number of clinical trials, and the improving healthcare infrastructure, are anticipated to propel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global glycomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Enzymes

Glycosidases

Glycosyltransferases

Neuraminidases

Sialyltransferases

Others

Instruments

Mass Spectrometers

HPLC

MALDI-TOF

Array systems

Others

Kits

Glycan Labeling Kits

Glycan Purification Kits

Glycan Release Kits

Others

Reagents

Glycoproteins

Monosaccharides

Oligosaccharides

Others

Breakup by Application:

Drug Discovery and Development

Diagnostics

Others

Breakup by End User:

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Contract Research Organizations (CROs)

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Asparia Glycomics, Bruker Corporation, Danaher Corporation, Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited), Merck KGaA, New England Biolabs, RayBiotech Life Inc., Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc. and Waters Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global glycomics market in 2022?
  • 2. What is the expected growth rate of the global glycomics market during 2023-2028?
  • 3. What are the key factors driving the global glycomics market?
  • 4. What has been the impact of COVID-19 on the global glycomics market?
  • 5. What is the breakup of the global glycomics market based on the product?
  • 6. What is the breakup of the global glycomics market based on the application?
  • 7. What is the breakup of the global glycomics market based on end user?
  • 8. What are the key regions in the global glycomics market?
  • 9. Who are the key players/companies in the global glycomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Glycomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Enzymes
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Glycosidases
      • 6.1.2.2 Glycosyltransferases
      • 6.1.2.3 Neuraminidases
      • 6.1.2.4 Sialyltransferases
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Mass Spectrometers
      • 6.2.2.2 HPLC
      • 6.2.2.3 MALDI-TOF
      • 6.2.2.4 Array systems
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Kits
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Glycan Labeling Kits
      • 6.3.2.2 Glycan Purification Kits
      • 6.3.2.3 Glycan Release Kits
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4 Reagents
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Glycoproteins
      • 6.4.2.2 Monosaccharides
      • 6.4.2.3 Oligosaccharides
      • 6.4.2.4 Others
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Academic and Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations (CROs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Asparia Glycomics
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bruker Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 New England Biolabs
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 RayBiotech Life Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Shimadzu Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takara Bio Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Waters Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis